USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/25710
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJoseph, Daniel
dc.date.accessioned2023-10-28T12:50:28Z
dc.date.accessioned2023-11-01T04:49:15Z
dc.date.available2023-10-28T12:50:28Z
dc.date.available2023-11-01T04:49:15Z
dc.date.issued2023
dc.identifier.citationJOSEPH, Daniel. Dyslipidemia in patient with cardiovascular diseases. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2023, vol. 10(3), anexa 1, p. 237. ISSN 2345-1467.en_US
dc.identifier.issn2345-1467
dc.identifier.urihttps://conferinta.usmf.md/wp-content/uploads/Culegerea-Rezumate-MJHS_10_3_2023_anexa1.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/25710
dc.descriptionUniversitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica Moldovaen_US
dc.description.abstractBackground. In the pursuit of comprehensive cardiovascular care, optimizing lipid management holds a paramount significance. Elevated levels of cholesterol, specifically low-density lipoprotein cholesterol (LDL-C), have long been established as a major risk factor for cardiovascular disease (CVD). Objective of the study. This study aims to document the clinical profile, diagnostic investigations, and treatment interventions of a 75-year-old male patient with dyslipidemia. Material and methods. This case report describes a 75-year-old male patient with complex medical history. A range of diagnostic tests were performed, including blood tests (CBC, glycemic profile, lipid profile), ECG, echocardiography, X-ray imaging to obtain objective data regarding the patient’s cardiac, metabolic and pulmonary status. Results. Patient characteristics: height 175 cm, weight 105 kg, BMI 34.3 kg/m2. He was known with controlled hypertension a type 2 decompensated diabetes mellitus. Vital signs: BP 110/70 mmHg, temperature 36.6°C, pulse 80/min, respira-tory rate 20/min, SpO2 94%. Dyslipidemia detected elevated levels of cholesterol (7,5mmol/l) and LDL-C (5,3mmol/l). Fasting blood glucose 9.2 mmol/L with elevated glycated hemoglobin. Normal hemoglobin, hematocrit, electrolytes; high blood urea nitrogen and creatinine. ECG showed atrial fibrillation, biventricular hypertrophy, repolarization changes. Echocardiography revealed previous mitral and aortic valvuloplasty (2016), induration, and calcification in ascending aortic walls. Treatment plan: pharmacotherapy for hypertension, anticoagulation, lipid management, anti-diabetic; lifestyle modifications, physical activity, mainly dietary restrictions. Conclusions. This research study will contribute to the existing medical knowledge by documenting the challenges and complexities associated with managing a patient with dyslipidemia, cardiovascular diseases, and multiple comorbidities.en_US
dc.languageen
dc.publisherInstituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldovaen_US
dc.relation.ispartofRevista de Științe ale Sănătății din Moldova: Moldovan Journal of Health Sciences: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 18-20 octombrie 2023, Chișinău, Republica Moldovaen_US
dc.subjectdyslipidemiaen_US
dc.subjectmajor cardiovascular risken_US
dc.titleDyslipidemia in patient with cardiovascular diseasesen_US
dc.typeOtheren_US
Appears in Collections:Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2023 nr. 3(10) Anexa 1

Files in This Item:
File Description SizeFormat 
MJHS_10_3_2023_anexa1_237.pdf150.22 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback